Advertisement
U.S. markets closed

Zoetis Inc. (ZTS)

NYSE - NYSE Delayed Price. Currency in USD
169.21+0.70 (+0.42%)
At close: 04:00PM EDT
169.47 +0.26 (+0.15%)
After hours: 07:57PM EDT
  • Dividend

    ZTS announced a cash dividend of 0.432 with an ex-date of Apr. 18, 2024

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close168.51
Open168.73
Bid168.88 x 800
Ask172.90 x 800
Day's Range167.41 - 171.14
52 Week Range151.03 - 201.92
Volume3,344,770
Avg. Volume2,739,759
Market Cap77.476B
Beta (5Y Monthly)0.87
PE Ratio (TTM)33.37
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield1.73 (1.03%)
Ex-Dividend DateApr 18, 2024
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-11% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for ZTS

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Zoetis Inc.
    Analyst Report: Zoetis IncZoetis Inc., a 2013 spinoff from Pfizer, focuses on the development, manufacture and commercialization of animal health vaccines and medicines, including parasiticides, anti-infectives, and medicated feed additives. The company develops products for both livestock and companion animals, and distributes its products globally. Zoetis is a component of the S&P 500 and has roughly 14,100 employees.
    Rating
    Fair Value
    Economic Moat
    8 days agoArgus Research
View more